{
    "id": 6383,
    "name": "childhood brain stem glioma",
    "source": "DOID",
    "definition": null,
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:6383",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT01182350",
            "title": "Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)",
            "phase": "Phase II",
            "recruitment": "Terminated",
            "therapies": [
                {
                    "id": 2115,
                    "therapyName": "Bevacizumab + Temozolomide",
                    "synonyms": null
                },
                {
                    "id": 2116,
                    "therapyName": "Bevacizumab + Erlotinib + Temozolomide",
                    "synonyms": null
                },
                {
                    "id": 1146,
                    "therapyName": "Bevacizumab + Erlotinib",
                    "synonyms": null
                },
                {
                    "id": 667,
                    "therapyName": "Bevacizumab",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT01661400",
            "title": "Anti-Angiogenic Therapy Post Transplant (ASCR) for Relapsed and Refractory Pediatric Solid Tumors",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 1148,
                    "therapyName": "Cyclophosphamide",
                    "synonyms": null
                },
                {
                    "id": 1475,
                    "therapyName": "Thalidomide",
                    "synonyms": null
                }
            ]
        }
    ]
}